Minor
Suspected
描述
Carbamazepine may modestly affect glucose homeostasis and potentially interact with metformin's antidiabetic effect through metabolic mechanisms.
机制
Carbamazepine has reported hyperglycemic effects and may impair insulin secretion; the interaction with metformin's biguanide mechanism is primarily pharmacodynamic.
临床意义
The interaction is generally minor; blood glucose monitoring is advisable when initiating or stopping carbamazepine in diabetic patients.
处理措施
Monitor blood glucose when initiating or changing carbamazepine doses; metformin dose adjustment is rarely required.